NCT04426695 · Interventional trial
Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19
Overall registry status Completed
Phase 1 · Phase 2
Conditions COVID-19
Delaware Valley sites
- Regeneron Study Site · Pennington, NJ · Mercer County
- Regeneron Study Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory